Synthesis of novel combinatorial drug delivery system (nCDDS) for co-delivery of 5-fluorouracil and leucovorin calcium for colon targeting and controlled drug release

References

• Kaplan SA, McConnell JD, Roehrborn CG, et al. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater. J Urol. 2006;175(1):217–220.
   PubMed Web of Science ®Google Scholar
• Feinglos MN, Thacker CR, Lobaugh B, et al. Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus. Diabetes Res Clin Pract. 1998;39(3):193–199.
   PubMedGoogle Scholar
• Moser M, Black HR. The role of combination therapy in the treatment of hypertension. Am J Hypertens. 1998;11(3):73S–78S.
   PubMedGoogle Scholar
• Ajun W, Yan S, Li G, et al. Preparation of aspirin and probucol in combination loaded chitosan nanoparticles and in vitro release study. Carbohydr Polym. 2009;75(4):566–574.
   Web of Science ®Google Scholar
• Wagner AD, Grothe W, Haerting J, et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol. 2006;24(18):2903–2909.
   PubMed Web of Science ®Google Scholar
• Presant CA, Wolf W, Waluch V, et al. Enhancement of fluorouracil uptake in human colorectal and gastric cancers by interferon or by high-dose methotrexate: an in vivo human study using noninvasive (19)F-magnetic resonance spectroscopy. J Clin Oncol. 2000;18(2):255–255.
   PubMedGoogle Scholar
• Lin FH, Lee YH, Jian CH, et al. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials. 2002;23(9):1981–1987.
   PubMed Web of Science ®Google Scholar
• Piedbois P, Buyse M, Rustum Y, et al. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate by the advanced colorectal cancer meta-analysis project. J Clin Oncol. 1992;10(6):896–903.
   PubMed Web of Science ®Google Scholar
• Erlichman C, Marsoni S, Seitz JF, et al. Event free and overall survival is increased by FUFA in resected B and C colon cancer: a prospective pooled analysis of 3 randomized trials. Proc Am Soc Clin Oncol. 1994;13:194.
   Google Scholar
• Francini G, Petrioli R, Marsili S, et al. Folinic acid plus 5-fluorouracil as adjuvant chemotherapy in colon cancer. Proc ASCO. 1994;13:196.
   Google Scholar
• O'Connell M. An intergroup trial of intensive course 5-FU and low dose leucovorin as surgical adjuvant therapy for high risk colon cancer. Proc ASCO. 1993;2:190.
   Google Scholar
• Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from national surgical adjuvant breast and bowel project protocol C-03. J Clin Oncol. 1993;11(10):1879–1887.
   PubMed Web of Science ®Google Scholar
• Meropol NJ, Rustum YM, Petrelli NJ, et al. A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer. Cancer Chemother Pharmacol. 1996;37(6):581–586.
   PubMedGoogle Scholar
• Zhang H, Zhao C, Cao H, et al. Hyperbranched poly(amine-ester) based hydrogels for controlled multi-drug release in combination chemotherapy. Biomaterials. 2010;31(20):5445–5454.
   PubMedGoogle Scholar
• Liu J, Huang Y, Kumar A, et al. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv. 2014;32(4):693–710.
   PubMed Web of Science ®Google Scholar
• Kratz F, Warnecke A. Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems. J Control Release. 2012;164(2):221–235.
   PubMed Web of Science ®Google Scholar
• Chen S, Jiang F, Cao Z, et al. Photo, pH, and thermo triple-responsive spiropyran-based copolymer nanoparticles for controlled release. Chem Commun. 2015;51(63):12633–12636.
   PubMedGoogle Scholar
• Chen L, Jiang T, Cai C, et al. Polypeptide-based “smart” micelles for dual-drug delivery: a combination study of experiments and simulations. Adv Healthc Mater. 2014;3(9):1508–1517.
   PubMedGoogle Scholar
• Floyd JA, Galperin A, Ratner BD. Drug encapsulated polymeric microspheres for intracranial tumor therapy: a review of the literature. Adv Drug Deliv Rev. 2015;91:23–37.
   PubMed Web of Science ®Google Scholar
• Probst CE, Zrazhevskiy P, Bagalkot V, et al. Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv Drug Deliv Rev. 2013;65(5):703–718.
   PubMed Web of Science ®Google Scholar
• Khan KU, Akhtar N, Minhas MU. Poloxamer-407-co-poly (2-acrylamido-2-methylpropane sulfonic acid) cross-linked nanogels for solubility enhancement of olanzapine: synthesis, characterization, and toxicity evaluation. AAPS PharmSciTech. 2020;21(5):1–15.
   Web of Science ®Google Scholar
• Khan KU, Minhas MU, Sohail M, et al. Synthesis of PEG-4000-co-poly (AMPS) nanogels by cross-linking polymerization as highly responsive networks for enhancement in meloxicam solubility. Drug Dev Ind Pharm. 2021;47(3):465–476.
   PubMed Web of Science ®Google Scholar
• Oh JK, Lee DI, Park JM. Biopolymer-based microgels/nanogels for drug delivery applications. Prog Polym Sci. 2009;34(12):1261–1282.
   Web of Science ®Google Scholar
• Suhail M, Rosenholm JM, Minhas MU, et al. Nanogels as drug-delivery systems: a comprehensive overview. Ther Deliv. 2019;10(11):697–717.
   PubMed Web of Science ®Google Scholar
• Khan KU, Minhas MU, Badshah SF, et al. Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs. Life Sci. 2022;291:120301.
   PubMedGoogle Scholar
• Asghar S, Akhtar N, Minhas MU, et al. Bi-polymeric spongy matrices through cross-linking polymerization: synthesized and evaluated for solubility enhancement of acyclovir. AAPS PharmSciTech. 2021;22(5):1–16.
   Google Scholar
• Rizvi SSB, Akhtar N, Minhas MU, et al. Synthesis and characterization of carboxymethyl chitosan nanosponges with cyclodextrin blends for drug solubility improvement. Gels. 2022;8(1):55.
   PubMedGoogle Scholar
• Khan KU, Minhas MU, Badshah SF, et al. β-cyclodextrin modification by cross-linking polymerization as highly porous nanomatrices for olanzapine solubility improvement; synthesis, characterization and bio-compatibility evaluation. J Drug Deliv Sci Technol. 2022;67:102952.
   Web of Science ®Google Scholar
• Minhas MU, Ahmad S, Khan KU, et al. Synthesis and evaluation of polyethylene glycol-4000-co-poly (AMPS) based hydrogel membranes for controlled release of mupirocin for efficient wound healing. Curr Drug Deliv. 2022;19.
   Google Scholar
• Butt H, Minhas MU, Khan KU, et al. Cross-linking polymerization of beta-cyclodextrin with acrylic monomers; characterization and study of drug carrier properties. Polym Bull. 2022;1–22.
   Google Scholar
• Abdullah O, Usman Minhas M, Ahmad M, et al. Synthesis, optimization, and evaluation of polyvinyl alcohol-based hydrogels as controlled combinatorial drug delivery system for colon cancer. Adv Polym Technol. 2018;37(8):3348–3363.
   Google Scholar
• Santiago LA, Valerio V, Yolo R. Acute oral toxicity study of the crude ethanolic leaf extract of ficus pseudopalma Blanco (Moraceae) in Sprague Dawley rats. Int J Res Dev Pharm Sci. 2014;2(6):674–679.
   Google Scholar
• Badshah SF, Akhtar N, Minhas MU, et al. Porous and highly responsive cross-linked β-cyclodextrin based nanomatrices for improvement in drug dissolution and absorption. Life Sci. 2021;267:118931.
   PubMed Web of Science ®Google Scholar
• Saleem A, Akhtar N, Minhas MU, et al. Highly responsive chitosan-co-poly(MAA) nanomatrices through cross-linking polymerization for solubility improvement. Gels. 2022;8(3):196.
   PubMedGoogle Scholar
• Barkat K, Ahmad M, Usman Minhas M, et al. Development and characterization of pH-responsive polyethylene glycol-co-poly (methacrylic acid) polymeric network system for colon target delivery of oxaliplatin: its acute oral toxicity study. Adv Polym Technol. 2018;37(6):1806–1822.
   Web of Science ®Google Scholar
• Patil MP, Gaikwad NJ. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions. Acta Pharm. 2009;59(1):57–65.
   PubMedGoogle Scholar
• Khalid I, Ahmad M, Minhas MU, et al. Preparation and characterization of alginate-PVA-based semi-IPN: controlled release pH-responsive composites. Polym Bull. 2018;75(3):1075–1025.
   Google Scholar
• Mansur HS, Oréfice RL, Mansur AA. Characterization of poly (vinyl alcohol)/poly (ethylene glycol) hydrogels and PVA-derived hybrids by small-angle X-ray scattering and FTIR spectroscopy. Polymer. 2004;45(21):7193–7202.
   Web of Science ®Google Scholar
• Li P, Wang Y, Peng Z, et al. Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends. Carbohydr Polym. 2011;85(3):698–704.
   Web of Science ®Google Scholar
• Ranjha NM, Mudassir J, Sheikh ZZ. Synthesis and characterization of pH-sensitive pectin/acrylic acid hydrogels for verapamil release study. Iran Polym J. 2011;20(2):147–159.
   Web of Science ®Google Scholar
• Rastogi PK, Krishnamoorthi S, Ganesan V. Synthesis, characterization, and ion exchange voltammetry study on 2-acrylamido-2-methylpropane sulphonic acid and N-(hydroxymethyl) acrylamide-based copolymer. J Appl Polym Sci. 2012;123(2):929–935.
   Web of Science ®Google Scholar
• Azmeera V, Adhikary P, Krishnamoorthi S. Synthesis and characterization of graft copolymer of dextran and 2-acrylamido-2-methylpropane sulphonic acid. Int J Carbohydr Chem. 2012;2012:1–7.
   Google Scholar
• Ganguly K, Aminabhavi TM, Kulkarni AR. Colon targeting of 5-fluorouracil using polyethylene glycol cross-linked chitosan microspheres enteric coated with cellulose acetate phthalate. Ind Eng Chem Res. 2011;50(21):11797–11807.
   Web of Science ®Google Scholar
• Fernandez M, et al. Characterization of solid dispersions of piroxicam/polyethylene glycol 4000. Int J Pharm. 1992;84(2):197–202.
   Web of Science ®Google Scholar
• Fares MM, Tahboub YR, Khatatbeh ST, et al. Eco-Friendly, vascular shape and interpenetrating poly (acrylic acid) grafted pectin hydrogels; biosorption and desorption investigations. J Polym Environ. 2011;19(2):431–439.
   Google Scholar
• Mishra RK, Datt M, Banthia AK. Synthesis and characterization of pectin/PVP hydrogel membranes for drug delivery system. AAPS PharmSciTech. 2008;9(2):395–403.
   PubMed Web of Science ®Google Scholar
• Das N. Preparation methods and properties of hydrogel: a review. Int J Pharm Pharm Sci. 2013;5(3):112–117.
   Google Scholar
• Kim B, Flamme KL, Peppas NA. Dynamic swelling behavior of pH-sensitive anionic hydrogels used for protein delivery. J Appl Polym Sci. 2003;89(6):1606–1613.
   Web of Science ®Google Scholar
• Shah S, Ranjha NM, Javaid Z. Development and evaluation of pH-dependent interpenetrating network of acrylic acid/polyvinyl alcohol. Iran Polym J. 2013;22(11):811–820.
   Google Scholar
• Pourjavadi A, Ghasemzadeh H, Mojahedi F. Swelling properties of CMC-g-poly (AAm-co-AMPS) superabsorbent hydrogel. J Appl Polym Sci. 2009;113(6):3442–3449.
   Web of Science ®Google Scholar
• Ravindra S, Mohan YM, Varaprasad K, et al. Surfactant-modified poly (acrylamide-co-acrylamido propane sulphonic acid) hydrogels. Int J Polym Mater. 2009;58(5):278–296.
   Web of Science ®Google Scholar
• Chang H-I, Perrie Y, Coombes A. Delivery of the antibiotic gentamicin sulphate from precipitation cast matrices of polycaprolactone. J Control Release. 2006;110(2):414–421.
   PubMedGoogle Scholar
• Butte K, Momin M, Deshmukh H. Optimisation and in vivo evaluation of pectin based drug delivery system containing curcumin for colon. Int J Biomater. 2014;110:1150–1157.
   Google Scholar
• Bao Y, Ma J, Li N. Synthesis and swelling behaviors of sodium carboxymethyl cellulose-g-poly (AA-co-AM-co-AMPS)/MMT superabsorbent hydrogel. Carbohydr Polym. 2011;84(1):76–82.
   Web of Science ®Google Scholar